Michael Fung

5.0k total citations · 1 hit paper
53 papers, 3.4k citations indexed

About

Michael Fung is a scholar working on Immunology, Virology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Fung has authored 53 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 20 papers in Virology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Fung's work include HIV Research and Treatment (20 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Complement system in diseases (14 papers). Michael Fung is often cited by papers focused on HIV Research and Treatment (20 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Complement system in diseases (14 papers). Michael Fung collaborates with scholars based in United States, Norway and Switzerland. Michael Fung's co-authors include Tom Eirik Mollnes, Haihong Zhong, Jiaqi Huang, Yihong Yao, Nan Shen, Xin Yao, Raffaella Faggioni, Richard May, Hilde Fure and Dorte Christiansen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Blood.

In The Last Decade

Michael Fung

52 papers receiving 3.4k citations

Hit Papers

Targeting interleukin-6 in inflammatory autoimmune diseas... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers

Michael Fung
Dag Kvale Norway
Kai Krohn Finland
Ali Ahmad Canada
Dorothy E. Lewis United States
Seema S. Ahuja United States
Kathleen A. Clouse United States
Miroslav Malkovský United States
Meng Wang China
Dag Kvale Norway
Michael Fung
Citations per year, relative to Michael Fung Michael Fung (= 1×) peers Dag Kvale

Countries citing papers authored by Michael Fung

Since Specialization
Citations

This map shows the geographic impact of Michael Fung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fung more than expected).

Fields of papers citing papers by Michael Fung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fung. The network helps show where Michael Fung may publish in the future.

Co-authorship network of co-authors of Michael Fung

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fung. A scholar is included among the top collaborators of Michael Fung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fung. Michael Fung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Haihong, April Davis, Maria Ouzounova, et al.. (2016). A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Research. 76(2). 480–490. 40 indexed citations
2.
Yao, Xin, Jiaqi Huang, Haihong Zhong, et al.. (2013). Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics. 141(2). 125–139. 529 indexed citations breakdown →
3.
Stephens, Geoffrey L., Ebony Benjamin, Anthony J. Coyle, et al.. (2011). IL‐9 is a Th17‐derived cytokine that limits pathogenic activity in organ‐specific autoimmune disease. European Journal of Immunology. 41(4). 952–962. 48 indexed citations
4.
Brekke, Ole‐Lars, Dorte Christiansen, Hilde Fure, et al.. (2008). Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood. Molecular Immunology. 45(14). 3804–3813. 53 indexed citations
5.
Baumann, Bettina C., et al.. (2007). Characterization of Natural Human Anti-Non-Gal Antibodies and Their Effect on Activation of Porcine Gal-Deficient Endothelial Cells. Transplantation. 84(2). 244–250. 47 indexed citations
6.
Fung, Michael, Barry Willer, Douglas B. Moreland, & John J. Leddy. (2006). A proposal for an evidenced-based emergency department discharge form for mild traumatic brain injury. Brain Injury. 20(9). 889–894. 46 indexed citations
7.
Castellheim, Albert, Anne Pharo, Michael Fung, Ola Didrik Saugstad, & Tom Eirik Mollnes. (2004). Complement C5a Is a Key Mediator of Meconium-Induced Neutrophil Activation. Pediatric Research. 57(2). 242–247. 17 indexed citations
8.
Lappegård, Knut Tore, Michael Fung, Grethe Bergseth, et al.. (2004). Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation. The Annals of Thoracic Surgery. 77(3). 932–941. 58 indexed citations
9.
Eichstaedt, Harald C., et al.. (2004). Anesthetic Induction With Ketamine Inhibits Platelet Activation Before, During, and After Cardiopulmonary Bypass in Baboons. Artificial Organs. 28(10). 959–962. 12 indexed citations
10.
Castellheim, Albert, et al.. (2003). Meconium Is a Potent Activator of Complement in Human Serum and in Piglets. Pediatric Research. 55(2). 310–318. 28 indexed citations
11.
Stahl, Gregory L., Yuanyuan Xu, Liming Hao, et al.. (2003). Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury. American Journal Of Pathology. 162(2). 449–455. 142 indexed citations
12.
Reimann, Keith A., et al.. (2002). A Humanized, Nondepleting Anti-CD4 Antibody That Blocks Virus Entry Inhibits Virus Replication in Rhesus Monkeys Chronically Infected with Simian Immunodeficiency Virus. AIDS Research and Human Retroviruses. 18(11). 747–755. 30 indexed citations
13.
Fung, Michael, et al.. (2001). Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. Journal of Thoracic and Cardiovascular Surgery. 122(1). 113–122. 72 indexed citations
14.
Fouts, Timothy, Alexandra Trkola, Michael Fung, & JOHN P. MOORE. (1998). Interactions of Polyclonal and Monoclonal Anti-Glycoprotein 120 Antibodies with Oligomeric Glycoprotein 120-Glycoprotein 41 Complexes of a Primary HIV Type 1 Isolate: Relationship to Neutralization. AIDS Research and Human Retroviruses. 14(7). 591–597. 40 indexed citations
15.
Weir, Rosemary E., et al.. (1998). Involvement of the Complement System in Antibody-Mediated Post-exposure Protection Against Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 14(3). 205–211. 13 indexed citations
16.
Jagodzińśki, Paweł P., Andrzej Fertala, Aleksander L. Sieroń, et al.. (1996). Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes. Virology. 226(2). 217–227. 28 indexed citations
17.
Safrit, Jeffrey T., Michael Fung, Charla Andrews, et al.. (1993). hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS. 7(1). 15–22. 79 indexed citations
18.
Ho, David D., et al.. (1992). Discontinuous Epitopes on gp120 Important in HIV-1 Neutralization. AIDS Research and Human Retroviruses. 8(8). 1337–1339. 11 indexed citations
20.
Fung, Michael, Chengyu Sun, R S Liou, et al.. (1990). Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.. The Journal of Immunology. 145(7). 2199–2206. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026